The US Food and Drug Administration (FDA) has approved ustekinumab-srlf (Imuldosa) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. This is the fifth ...

FDA approves Pfizer’s Hympavzi for routine prophylaxis in hemophilia A and B patients, offering a once-weekly dosing via auto-injector pen. Phase 3 trial showed Hympavzi reduced bleeding rates ...

SAN FRANCISCO, CA / ACCESSWIRE / October 16, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ('Jaguar') today announced that Jaguar ...

The FDA approval of HYMPAVZI was supported by the Phase III BASIS clinical trial. Credit: Andrey_Popov/Shutterstock. Pfizer has announced the approval of HYMPAVZI ...

The FDA has approved an ingestible event marker from the privately-held digital health company etectRx, as its rival “digital pill” company Proteus faces financial difficulties. Florida-based ...

In the ever-evolving world of health and wellness, finding the right supplement that genuinely supports your weight loss and ...

This is the second biosimilar approved in the US from Amgen and Allergan’s partnership, which has already got a biosimilar to Roche’s Avastin (bevacizumab) cancer drug backed by the FDA.

Many individuals seek practical solutions to enhance their physical performance and vitality in today’s fast-paced world.

Stelara is also one of the first 10 medications selected by CMS for drug price negotiation, which will go into effect at the start of 2026. Imuldosa is the fifth Stelar biosimilar to be approved for ...

A healthy diet in prostate cancer patients on active surveillance was associated with a reduced risk of progressing to a more ...

The lawsuit was filed in a Texas federal court Friday, roughly four months after the Supreme Court decided against undoing ...

Jaguar Health introduces US FDA-approved oral mucositis prescription product Gelclair in US: San Francisco, California Friday, October 18, 2024, 18:00 Hrs [IST] Jaguar Health, Inc ...